Coffee appears to change how your gut functions
It may be a slightly awkward topic, but many of us know the feeling: that cup of coffee that gets things moving. Research now suggests that regular coffee… read more.
It may be a slightly awkward topic, but many of us know the feeling: that cup of coffee that gets things moving. Research now suggests that regular coffee… read more.
ArriVent BioPharma, Inc. announced that the FURVENT (NCT05607550) Phase 3 trial evaluating firmonertinib monotherapy in patients with previously untreated, locally advanced or metastatic non-squamous non-small cell lung cancer… read more.
Priovant Therapeutics has published results from the Phase 2 portion of the BEACON study of oral brepocitinib in adults with cutaneous sarcoidosis (CS) in JAMA Dermatology. Dr Misha… read more.
When it comes to hormone-disrupting chemicals, people worry most about what they eat and drink and least about what they put on their skin, according to new research… read more.
Eli Lilly and Company announced positive results from ATTAIN-OSA, a Phase 3 clinical program evaluating the efficacy and safety of Foundayo (orforglipron) in adults with moderate-to-severe obstructive sleep apnea (OSA)… read more.
CRISPR Therapeutics has presented Phase 1b data for CTX310 in patients with severe hypertriglyceridemia (sHTG) in a late-breaking oral presentation at the AHA Scientific Sessions 2026. CTX310 is… read more.
They’re the blockbuster drugs transforming weight loss, helping millions of people to shed unwanted kilos. But while medications such as Ozempic and Wegovy may also improve women’s chances… read more.
Pharming announced that the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) has approved an extension of the marketing authorization of Joenja, an oral, selective phosphoinositide 3-kinase delta… read more.
Marea Therapeutics, a subsidiary of Lisata Therapeutics, has announced that MAR001 met all objectives in Part A of the Phase 2b TYDAL-TIMI 78 trial. MAR001 is a potential… read more.
Combining a symptom questionnaire with fractional exhaled nitric oxide (FeNO) testing could offer a simple, non-invasive way to identify women who need further respiratory assessment. Asthma is common… read more.
For people with painful knee osteoarthritis (OA) who are overweight or have obesity, everyday activities such as walking, climbing stairs and standing up from a chair can be… read more.
Altimmune has presented positive results from the Phase 2 RECLAIM trial of pemvidutide in adults with moderate-to-severe alcohol use disorder (AUD). Pemvidutide is an investigational, balanced 1:1 glucagon/GLP-1… read more.